PMID- 15785242 OWN - NLM STAT- MEDLINE DCOM- 20051121 LR - 20221207 IS - 1050-7256 (Print) IS - 1050-7256 (Linking) VI - 15 IP - 3 DP - 2005 Mar TI - CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. PG - 232-8 AB - Graves' disease (GD) is an autoimmune and polygenic disorder. Several studies have shown that human leukocyte antigen (HLA) class II and the cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene are involved in the genetic susceptibility. We performed a case control study on 150 patients with GD and 301 controls, matched for age and gender, to verify the association of three polymorphisms located in CTLA-4 region (A49G, [AT](n)-3'UTR, and CT60) and of HLA-DRB1 and DQB1 loci with the disease in an Italian population. The prevalence of patients with GD carrying the G allele of CT60 was significantly higher compared to control subjects (p = 0.02, odds ratio [OR] = 1.82). The allelic frequency of the G allele of CT60 was also significantly higher in patients with GD (p = 0.02). The G allele frequency of A49G in patients was significantly higher compared to control subjects (p = 0.04). The 280 allele phenotype frequency of (AT)(n)-3'UTR was also significantly higher in patients (p = 0.04). The G allele of A49G, the G allele of CT60, and the 280 allele of (AT)(n)-3'UTR microsatellite were significantly increased in patients with GD with thyroid-associated ophthalmopathy (TAO) compared to controls (p = 0.04, p = 0.03, and p = 0.02, respectively), however, we did not find any significant difference between TAO and non-TAO patients. We also found the HLA-DRB1*03 allele to be associated with GD; interestingly, the association of the CTLA-4 markers was independent from the HLA DRB1*03 status. These results highlight the role of the CTLA-4 locus, in addition to HLA, in the susceptibility to GD. Inside the CTLA-4 region, CT60 appears to be the most associated polymorphism to GD, however, further studies are needed to identify the etiologic variant. FAU - Petrone, Antonio AU - Petrone A AD - Department of Clinical Science, University of Rome La Sapienza, 00161 Rome, Italy. FAU - Giorgi, Gabriele AU - Giorgi G FAU - Galgani, Andrea AU - Galgani A FAU - Alemanno, Irene AU - Alemanno I FAU - Corsello, Salvatore M AU - Corsello SM FAU - Signore, Alberto AU - Signore A FAU - Di Mario, Umberto AU - Di Mario U FAU - Nistico, Lorenza AU - Nistico L FAU - Cascino, Isabella AU - Cascino I FAU - Buzzetti, Raffaella AU - Buzzetti R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Thyroid JT - Thyroid : official journal of the American Thyroid Association JID - 9104317 RN - 0 (5' Untranslated Regions) RN - 0 (Antigens, CD) RN - 0 (Antigens, Differentiation) RN - 0 (CTLA-4 Antigen) RN - 0 (CTLA4 protein, human) RN - 0 (DNA Primers) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQB1 antigen) RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) SB - IM MH - 5' Untranslated Regions MH - Antigens, CD MH - Antigens, Differentiation/*genetics MH - CTLA-4 Antigen MH - DNA Primers MH - Gene Frequency MH - Graves Disease/*genetics/*immunology MH - HLA-DQ Antigens/genetics MH - HLA-DQ beta-Chains MH - HLA-DR Antigens/genetics MH - HLA-DRB1 Chains MH - Histocompatibility Testing MH - Humans MH - Italy MH - Microsatellite Repeats MH - Phenotype MH - Polymerase Chain Reaction MH - *Polymorphism, Single Nucleotide MH - Reference Values MH - White People EDAT- 2005/03/24 09:00 MHDA- 2005/12/13 09:00 CRDT- 2005/03/24 09:00 PHST- 2005/03/24 09:00 [pubmed] PHST- 2005/12/13 09:00 [medline] PHST- 2005/03/24 09:00 [entrez] AID - 10.1089/thy.2005.15.232 [doi] PST - ppublish SO - Thyroid. 2005 Mar;15(3):232-8. doi: 10.1089/thy.2005.15.232.